July 2014 FDA Recall Drug by Wockhardt Usa Inc.
D-1541-2014 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Wockhardt Usa Inc. on July 24, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1541-2014

Reason for Recall
Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.
Initiated
07-24-2014
Reported
08-27-2014
Quantity
11,661 HDPE bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA

Batch or Lot Expiration Information

Lot# a) LN11005, Exp 04/15; LN11006; Exp 04/15; b) LN10979; Exp. 04/15, LN10980; Exp. 04/15